CN104398640A - Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof - Google Patents

Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof Download PDF

Info

Publication number
CN104398640A
CN104398640A CN201410617504.8A CN201410617504A CN104398640A CN 104398640 A CN104398640 A CN 104398640A CN 201410617504 A CN201410617504 A CN 201410617504A CN 104398640 A CN104398640 A CN 104398640A
Authority
CN
China
Prior art keywords
parts
chinese medicine
herba
medicine composition
semen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410617504.8A
Other languages
Chinese (zh)
Inventor
张丽红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410617504.8A priority Critical patent/CN104398640A/en
Publication of CN104398640A publication Critical patent/CN104398640A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicinal composition for treating prostatitis. The traditional Chinese medicinal composition comprises Salvia miltiorrhiza, radix paeoniae rubra, safflower, peach seed, Boswellia carteri, myrrh, Herba Lycopi, Herba Patriniae, Fructus Toosendan, Herba Taraxaci, dahurian angelica root, green tangerine peel, Fructus Foeniculi, Vaccaria segetalis, Semen Plantaginis and Amur Corktree Bark. The traditional Chinese medicinal composition has the efficacies of heat clearing, detoxifying, blood circulation invigorating, stasis removing, dampness removing, pain relieving, inflammation eliminating and sterilizing, has an obvious fundamental treatment effect on the prostatitis, and has the advantages of short medication time, small side effects, and no recurrence after curing.

Description

One treats prostatitic Chinese medicine composition and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine composition, especially one treats prostatitis Chinese medicine composition and preparation method.
Background technology
Prostatitis refers to prostate specific and the active chronic inflammation caused by non-specific infection, thus the whole body caused or local symptom.Divide according to the course of disease, acute prostatitis and chronic prostatitis can be divided into.
Acute prostatitis can have aversion to cold, heating, the General Symptoms such as weak.Local symptom is that perineum or suprapubic region territory have weight sense, increases the weight of when sitting or defecation, and to the radiation of the place such as waist, lower abdomen, back and thigh, if there is microabscess to be formed, the pain increased and can not defecation.Chronic prostatitis there will be slight frequent micturition, at ordinary times or urine time urethra scratchy, and urine stage casing or latter end can the secretions of adularescent ooze, and body part has pain phenomenon at ordinary times, generally show penis, testis, lower abdomen, perineum place etc., but pain not obvious.
The prostatitic cause of disease is complicated, particularly the performance of chronic prostatitis syndrome shape differs, the cause of disease is obscure, makes a definite diagnosis difficulty, and medicine is difficult to arrive at focus, easily cause prostatosis obstinate, recurrent exerbation, existing western medicine mainly based on antibiotic therapy, though part disease can be improved, but cannot effect a radical cure, and long-term taking antibiotic is larger to the person.
The prostatitic medicament categories of existing treatment by Chinese herbs is various, but the course for the treatment of is long, and curative effect is slow, and cannot break away from the dependence to western medicine antibiotics.
Therefore, one effectively can effect a radical cure prostatitis, short treating period, and side effect is little, and the medicine not easily recurred is badly in need of being invented.
Summary of the invention
Treat prostatitic medicine for obtaining new and effective being applicable to, the present inventor through a large amount of further investigations, after having paid sufficient creative work, thus completes the present invention to this.
The present invention relates to one and treat prostatic Chinese medicine composition, described Chinese medicine composition comprises Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Flos Carthami, Semen Persicae, Olibanum, Myrrha, Herba Lycopi, Herba Patriniae, Fructus Toosendan, Herba Taraxaci, the Radix Angelicae Dahuricae, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi, Semen Vaccariae, Semen Plantaginis, Cortex Phellodendri.
Exemplify as one is exemplary, in described middle compositions, with parts by weight, its concrete constituent content is as follows:
Radix Salviae Miltiorrhizae 10-20 part, Radix Paeoniae Rubra 5-15 part, Flos Carthami 5-15 part, Semen Persicae 5-15 part, Olibanum 3-9 part, Myrrha 3-9 part, Herba Lycopi 5-15 part, Herba Patriniae 25-35 part, Fructus Toosendan 5-15 part, Herba Taraxaci 25-35 part, Radix Angelicae Dahuricae 5-15 part, Pericarpium Citri Reticulatae Viride 5-15 part, Fructus Foeniculi 5-15 part, Semen Vaccariae 5-15 part, Semen Plantaginis 5-15 part, Cortex Phellodendri 5-15 part.
Further, Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, 10 parts, Flos Carthami, 10 parts, Semen Persicae, Olibanum 6 parts, Myrrha 6 parts, Herba Lycopi 10 parts, Herba Patriniae 30 parts, Fructus Toosendan 10 parts, Herba Taraxaci 30 parts, the Radix Angelicae Dahuricae 10 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi 10 parts, Semen Vaccariae 10 parts, Semen Plantaginis 10 parts, Cortex Phellodendri 10 parts.
Chinese medicine composition described above, its preparation method is: take all kinds of medical material mix homogeneously according to above-mentioned weight portion, soak 2 hours, the water adding 10 times of volumes boils, and changes little fire and boils medicine 20 minutes again, pour in container by the traditional Chinese medicine liquid boiled after boiling, the water that former medicinal residues add 10 times of volumes again repeats to boil medicine one time, outwelled by medicinal residues, the traditional Chinese medicine liquid boiled twice is mixed into together, is the decoction of described Chinese medicine.
The form of described Chinese medicine composition is not limited to decoction, also can be powder, honeyed pill etc.
One as above treats prostatitic Chinese medicine composition, and its using method is: an auxiliary medicine is taken at twice, sooner or later respectively once.
Beneficial effect: one of the present invention treats prostatitic Chinese medicine composition, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, removing damp and stopping pain, anti-inflammation and sterilization, have prostatitis and significantly effect a radical cure effect, administration time is short, and side effect is little, not easily recurs after healing.
Detailed description of the invention
Below by specific embodiment, the present invention is described in detail; but the purposes of these exemplary embodiments and object are only used for exemplifying the present invention; not any type of any restriction is formed to real protection scope of the present invention, more non-protection scope of the present invention is confined to this.
Embodiment 1
One treats prostatitic Chinese medicine composition, becomes (every part of 1g) by following component parts by weights array
Radix Salviae Miltiorrhizae 10 parts, Radix Paeoniae Rubra 5 parts, 5 parts, Flos Carthami, 5 parts, Semen Persicae, Olibanum 3 parts, Myrrha 3 parts, Herba Lycopi 5 parts, Herba Patriniae 25 parts, Fructus Toosendan 5 parts, Herba Taraxaci 25 parts, the Radix Angelicae Dahuricae 5 parts, 5 parts, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi 5 parts, Semen Vaccariae 5 parts, Semen Plantaginis 5 parts, Cortex Phellodendri 5 parts.
Concrete preparation method is as follows:
All kinds of medical material mix homogeneously is taken according to above-mentioned weight portion, soak 2 hours, the water adding 10 times of volumes boils, change little fire after boiling to boil medicine again 20 minutes, pour in container by the traditional Chinese medicine liquid boiled, the water that former medicinal residues add 10 times of volumes again repeats to boil medicine one time, is outwelled by medicinal residues, the traditional Chinese medicine liquid boiled twice is mixed into together, is the decoction of described Chinese medicine.
Using method a: auxiliary medicine is taken at twice, sooner or later respectively once.
Embodiment 2
One treats prostatitic Chinese medicine composition, becomes (every part of 1g) by following component parts by weights array
Radix Salviae Miltiorrhizae 20 parts, Radix Paeoniae Rubra 15 parts, 15 parts, Flos Carthami, 15 parts, Semen Persicae, Olibanum 9 parts, Myrrha 9 parts, Herba Lycopi 15 parts, Herba Patriniae 35 parts, Fructus Toosendan 15 parts, Herba Taraxaci 35 parts, the Radix Angelicae Dahuricae 15 parts, 15 parts, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi 15 parts, Semen Vaccariae 15 parts, Semen Plantaginis 15 parts, Cortex Phellodendri 15 parts.
Concrete preparation method and using method are with embodiment 1.
Embodiment 3
One treats prostatitic Chinese medicine composition, becomes (every part of 1g) by following component parts by weights array
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, 10 parts, Flos Carthami, 10 parts, Semen Persicae, Olibanum 6 parts, Myrrha 6 parts, Herba Lycopi 10 parts, Herba Patriniae 30 parts, Fructus Toosendan 10 parts, Herba Taraxaci 30 parts, the Radix Angelicae Dahuricae 10 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi 10 parts, Semen Vaccariae 10 parts, Semen Plantaginis 10 parts, Cortex Phellodendri 10 parts.Concrete preparation method and using method are with embodiment 1.
Performance test:
The prostatitic Chinese medicine composition for the treatment of of the present invention is to prostatitic therapeutic efficiency.Clinical subjects: Chinese medicine composition of the present invention in 2012 to 2014 the routine patients of clinical observation prostatitis 120, age 30-68 year, the course of disease 7 months-3 years.
Diagnostic criteria: traditional Chinese medical science identification is formulated by national unified editing institute of traditional Chinese medicine teaching material;
Doctor trained in Western medicine is formulated by national unified editing doctor trained in Western medicine institute teaching material.
Therapeutic scheme: experimental group: use one of the present invention to treat prostatitic Chinese medicine composition, every day one is secondary, and every day services once sooner or later, uses two courses for the treatment of continuously, namely two weeks, and checks after 3 months.Matched group: the patient simultaneously adding up other therapeutic scheme treatment between these 3 years, comprises the patient using western medicine and other treatment by Chinese herbs, and the patient totally 120 of both combinations.
Efficacy evaluation:
Recovery from illness: after terminating the course for the treatment of, symptom, sign disappear, laboratory leading indicator recovery or close normal.
Effective: after terminating the course for the treatment of, symptom, sign disappear substantially, and laboratory leading indicator also has clear improvement.
Effective: after terminating the course for the treatment of, symptom, sign alleviate, and laboratory leading indicator is also improved.
Invalid: after terminating the course for the treatment of, symptom, sign and laboratory leading indicator are not improved.
Brief summary: after treatment, two groups of total effects of Drug therapy have significant difference, and experimental group Yu shows rate and reaches 85.8%, total effective rate reaches 97.5%, apparently higher than matched group, and further consultation after three months, relapse rate is 0.83%, is starkly lower than matched group (see table 1).
Table 12 groups of prostatitis patient therapeutic effect compare [example (%)]
Case and clinical effectiveness:
The clinical practice of Chinese medicine composition of the present invention before the treatment in row adenitis and effect.
1, Mr. Wang, man, 38 years old, perineum and scrotum, urethralgia, dripped white, urethra scorching hot sense, urine retention, bitter taste, sexual hypofunction.Take the present invention to treat prostatitic Chinese medicine composition and treat, after 2 courses for the treatment of, patients symptomatic disappears, and prostate quality is soft, without tenderness, and examination of prostatic fluid WRC1-2/HP, lecithin +++, after 3 months, check is without recurring.
2, Mr. Kan, man 45 years old, Urinary deutostoma has micro-white secretions, and urine has surplus energy sense, hypogastric region and perineal position sense of discomfort, mild pain during ejaculation, the sexual hypofunctions such as premature ejaculation, insomnia and dreamful sleep.Take the present invention to treat prostatitic Chinese medicine composition and treat, after 2 courses for the treatment of, patients symptomatic disappears, and after 3 months, check is without recurrence.
To sum up, one of the present invention is treated prostatitic medicine and is had lasting medicine, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, removing damp and stopping pain, anti-inflammation and sterilization, and have prostatitis and significantly effect a radical cure effect, administration time is short, and side effect is little, not easily recurs after healing.
Should be appreciated that the purposes of these embodiments is only not intended to for illustration of the present invention limit the scope of the invention.In addition; also should understand; after having read technology contents of the present invention, those skilled in the art can make various change, amendment and/or modification to the present invention, and these all equivalent form of values fall within the protection domain that the application's appended claims limits equally.

Claims (5)

1. treat a prostatic Chinese medicine composition, described Chinese medicine composition comprises Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Flos Carthami, Semen Persicae, Olibanum, Myrrha, Herba Lycopi, Herba Patriniae, Fructus Toosendan, Herba Taraxaci, the Radix Angelicae Dahuricae, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi, Semen Vaccariae, Semen Plantaginis, Cortex Phellodendri.
2. Chinese medicine composition as claimed in claim 1, it is characterized in that: with parts by weight, its concrete constituent content is as follows:
Radix Salviae Miltiorrhizae 10-20 part, Radix Paeoniae Rubra 5-15 part, Flos Carthami 5-15 part, Semen Persicae 5-15 part, Olibanum 3-9 part, Myrrha 3-9 part, Herba Lycopi 5-15 part, Herba Patriniae 25-35 part, Fructus Toosendan 5-15 part, Herba Taraxaci 25-35 part, Radix Angelicae Dahuricae 5-15 part, Pericarpium Citri Reticulatae Viride 5-15 part, Fructus Foeniculi 5-15 part, Semen Vaccariae 5-15 part, Semen Plantaginis 5-15 part, Cortex Phellodendri 5-15 part.
3. Chinese medicine composition as claimed in claim 1 or 2, it is characterized in that: with parts by weight, its concrete constituent content is as follows:
Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, 10 parts, Flos Carthami, 10 parts, Semen Persicae, Olibanum 6 parts, Myrrha 6 parts, Herba Lycopi 10 parts, Herba Patriniae 30 parts, Fructus Toosendan 10 parts, Herba Taraxaci 30 parts, the Radix Angelicae Dahuricae 10 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Fructus Foeniculi 10 parts, Semen Vaccariae 10 parts, Semen Plantaginis 10 parts, Cortex Phellodendri 10 parts.
4. Chinese medicine composition as claimed in claim 1 or 2, its preparation method is:
All kinds of medical material mix homogeneously is taken according to above-mentioned weight portion, soak 2 hours, the water adding 10 times of volumes boils, change little fire after boiling to boil medicine again 20 minutes, pour in container by the traditional Chinese medicine liquid boiled, the water that former medicinal residues add 10 times of volumes again repeats to boil medicine one time, is outwelled by medicinal residues, the traditional Chinese medicine liquid boiled twice is mixed into together, is the decoction of described Chinese medicine.
5. Chinese medicine composition as claimed in claim 1, its medicine type can also be honeyed pill, powder.
CN201410617504.8A 2014-11-05 2014-11-05 Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof Pending CN104398640A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410617504.8A CN104398640A (en) 2014-11-05 2014-11-05 Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410617504.8A CN104398640A (en) 2014-11-05 2014-11-05 Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104398640A true CN104398640A (en) 2015-03-11

Family

ID=52636349

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410617504.8A Pending CN104398640A (en) 2014-11-05 2014-11-05 Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104398640A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012521A (en) * 2015-07-24 2015-11-04 侯志廷 Traditional Chinese medicine composition treating prostate diseases
CN105148123A (en) * 2015-07-25 2015-12-16 王军 Traditional Chinese medicinal composition for treating prostatitis
CN106822554A (en) * 2017-04-04 2017-06-13 李少伦 One kind treats prostatitic medicine and preparation method thereof
CN107648543A (en) * 2017-11-21 2018-02-02 王洪波 A kind of Chinese medicine composition for treating prostate and preparation method thereof
CN111388589A (en) * 2020-03-16 2020-07-10 佰氏健康(广州)大健康科技有限公司 Traditional Chinese medicine composition for treating prostatitis
CN113144153A (en) * 2021-02-11 2021-07-23 陆思宇 A Chinese medicinal patch for treating prostate diseases

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012521A (en) * 2015-07-24 2015-11-04 侯志廷 Traditional Chinese medicine composition treating prostate diseases
CN105148123A (en) * 2015-07-25 2015-12-16 王军 Traditional Chinese medicinal composition for treating prostatitis
CN106822554A (en) * 2017-04-04 2017-06-13 李少伦 One kind treats prostatitic medicine and preparation method thereof
CN107648543A (en) * 2017-11-21 2018-02-02 王洪波 A kind of Chinese medicine composition for treating prostate and preparation method thereof
CN111388589A (en) * 2020-03-16 2020-07-10 佰氏健康(广州)大健康科技有限公司 Traditional Chinese medicine composition for treating prostatitis
CN113144153A (en) * 2021-02-11 2021-07-23 陆思宇 A Chinese medicinal patch for treating prostate diseases

Similar Documents

Publication Publication Date Title
CN100563690C (en) A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc
CN104398640A (en) Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof
CN103028091B (en) Traditional Chinese medicine composition for treating damp heat of liver and gallbladder
CN103211932B (en) Traditional Chinese medicine composition for treating rheumatism
CN103316295B (en) Traditional Chinese composition for treating rheumatic arthritis
CN103520579A (en) Medicinal liquor used for treating lumbocrural pain, hyperostosis and sciatica
CN101972464A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN105233145A (en) Musk medicine for dispelling wind
CN102961483B (en) Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof
CN104840599A (en) Medicine for treating ankylosing spondylitis
CN104258304A (en) Medicated wine for meridian unblocking, wind dispelling, collaterals activating and pain relieving
CN102188595A (en) Chinese medicine composition for treating arthritis and preparation method thereof
CN104587252A (en) Traditional Chinese medicine composition for treating kidney stones
CN103961671A (en) Chili-wild pepper-pepper rheumatism pain relieving solution
CN103933171A (en) Externally applied medicinal liquor for treating lumbar and leg ache
CN106860659A (en) A kind of composition for treating cold acute filthy disease disease and preparation method thereof
CN101361868B (en) Traditional Chinese medicine combination for treating rheumatism
CN103223012B (en) External traditional Chinese medicine composition for treating sudden sprain in lumbar region and acute chest pain and preparation method thereof
CN103356959B (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN102949507A (en) Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof
CN106728060A (en) It is a kind of to treat externally applied ointment of rheumatism and preparation method thereof
CN105688096A (en) Traditional Chinese medicine composition for treating gout
CN105664129A (en) Traditional Chinese medicine composition for treating gout
CN106389943A (en) Traditional Chinese medicinal composition for treating back myofascitis
CN105148051A (en) Traditional Chinese medicinal composition for treating chronic prostatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150311